CD8A and neoplasm: We analyzed tumor-infiltrating lymphocytes (TILs) by flow cytometry on day 7 post CAR T-vax treatment and observed substantially increased endogenous CD8+ TILs and a trend toward increased CD4+ cells (Figure 2A).